Cargando…

Computational study on new natural compound agonists of dopamine receptor

Dopamine receptor, a polypeptide chain composed of 7 hydrophobic transmembrane regions, is a new and vital drug target, especially Dopamine receptor 2(D2). Targeting dopamine receptors, Dopamine receptor agonists are a class of drugs similar in function and structure to dopamine and can directly act...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Hui, Yang, Wenzhuo, Xi, Jianxin, Wang, Zhenhua, Lu, Han, Du, Zhishan, Li, Weihang, Wu, Bo, Jiang, Shanshan, Peng, Yida, liu, Jingyi, liu, Luwei, Zhang, Xiangheng, Feng, Jiachun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266345/ https://www.ncbi.nlm.nih.gov/pubmed/34170848 http://dx.doi.org/10.18632/aging.203180

Ejemplares similares

Computational research of mTORC1 inhibitor on cerebral ischemia-reperfusion injury
por: Li, Hui, et al.
Publicado: (2021)

Computational study on new natural compound agonists of stimulator of interferon genes (STING)
por: Zhong, Sheng, et al.
Publicado: (2019)

Computational study on new natural compound inhibitors of indoleamine 2,3-dioxygenase 1
por: Jiang, Shanshan, et al.
Publicado: (2020)

Effective natural inhibitors targeting poly ADP-ribose polymerase by computational study
por: Zhong, Sheng, et al.
Publicado: (2021)

Computational study on natural compounds inhibitor of c-Myc
por: Ren, Junan, et al.
Publicado: (2020)

Computational study on novel natural inhibitors targeting BCL2
por: Lv, Xiaye, et al.
Publicado: (2021)

Computational research of Belnacasan and new Caspase-1 inhibitor on cerebral ischemia reperfusion injury
por: Li, Hui, et al.
Publicado: (2022)

The Mechanism and Pathways of Dopamine and Dopamine Agonists in Prolactinomas
por: Liu, Xiaoshuang, et al.
Publicado: (2019)

Dopamine Agonists and Pathologic Behaviors
por: Kelley, Brendan J., et al.
Publicado: (2012)

Dopamine Agonists for Pituitary Adenomas
por: Cooper, Odelia, et al.
Publicado: (2018)

Identification of Natural Compound Carnosol as a Novel TRPA1 Receptor Agonist
por: Zhai, Chenxi, et al.
Publicado: (2014)

The treatment of Parkinson's disease with dopamine agonists
por: Konta, Brigitte, et al.
Publicado: (2008)

Impulse control disorders and dopamine agonists
por: Martins, D., et al.
Publicado: (2021)

Experience with Dopamine Agonists in the Treatment of Prolactinomas
por: Barabash, Nadiya Ye., et al.
Publicado: (2022)

The effects of dopamine and dopamine receptor agonists on the phototransduction cascade of frog rods
por: Nikolaeva, Darya A., et al.
Publicado: (2019)

Dopamine D(4) Receptor-Selective Compounds Reveal Structure–Activity Relationships that Engender Agonist Efficacy
por: Keck, Thomas M., et al.
Publicado: (2019)

The side effects of dopamine receptor agonist drugs in Chinese prolactinoma patients: a cross sectional study
por: Ke, Xiaoan, et al.
Publicado: (2022)

Dopamine dysregulation syndrome after prescription of dopamine agonists: a case report
por: Costa, M.L., et al.
Publicado: (2022)

A PARP1-related prognostic signature constructing and PARP-1 inhibitors screening for glioma
por: Li, Hui, et al.
Publicado: (2022)

Pathological gambling and dopamine agonists: A phenotype?
por: Pinder, Roger M
Publicado: (2007)

Dopamine Agonist Therapy in Advanced Parkinson’s Disease
por: Reichmann, Heinz
Publicado: (2009)

Non-ergot dopamine agonists and heart failure
por: Şener, Yusuf Ziya, et al.
Publicado: (2019)

Predictors of dopamine agonist resistance in prolactinoma patients
por: Vermeulen, Elle, et al.
Publicado: (2020)

Computational Study on New Natural Compound Inhibitors of Pyruvate Dehydrogenase Kinases
por: Zhou, Xiaoli, et al.
Publicado: (2016)

Dopamine agonist responsive burning mouth syndrome: Report of eight cases
por: Du, Qi-Cui, et al.
Publicado: (2021)

Dopamine-Depleted Dopamine Transporter Knockout (DDD) Mice: Dyskinesia with L-DOPA and Dopamine D1 Agonists
por: Pogorelov, Vladimir M., et al.
Publicado: (2023)

Role of dopamine and selective dopamine receptor agonists on mouse ductus arteriosus tone and responsiveness
por: Crockett, Stacey L., et al.
Publicado: (2019)

Inhibitory Effects of Dopamine Receptor D(1) Agonist on Mammary Tumor and Bone Metastasis
por: Minami, Kazumasa, et al.
Publicado: (2017)

Computational study of novel natural inhibitors targeting aminopeptidase N(CD13)
por: Ge, Junliang, et al.
Publicado: (2020)

Publicity and reports of behavioral addictions associated with dopamine agonists
por: Gendreau, Katherine E., et al.
Publicado: (2016)

Resistance to Dopamine Agonists in Pituitary Tumors: Molecular Mechanisms
por: Pivonello, Claudia, et al.
Publicado: (2022)

Dopamine agonist monotherapy utilization in patients with Parkinson’s disease
por: Frazer, Monica, et al.
Publicado: (2022)

Successful treatment of dopamine dysregulation syndrome with dopamine D(2) partial agonist antipsychotic drug
por: Mizushima, Jin, et al.
Publicado: (2012)

Case Report: Temozolomide Treatment of Refractory Prolactinoma Resistant to Dopamine Agonists
por: Tang, Hao, et al.
Publicado: (2021)

Selected using bioinformatics and molecular docking analyses, PHA-793887 is effective against osteosarcoma
por: Wu, Bo, et al.
Publicado: (2021)

Dopamine supersensitivity psychosis and dopamine partial agonist: A retrospective survey of failure of switching to aripiprazole in schizophrenia
por: Takase, Masayuki, et al.
Publicado: (2015)

Dopamine receptor agonists mechanism of actions on glucose lowering and their connections with prolactin actions
por: Chien, Hung-Yu, et al.
Publicado: (2023)

New natural compound inhibitors of PDGFRA (platelet-derived growth factor receptor α) based on computational study for high−grade glioma therapy
por: Yang, Wenzhuo, et al.
Publicado: (2023)

Pituitary surgery for small prolactinomas as an alternative to treatment with dopamine agonists
por: Babey, Muriel, et al.
Publicado: (2010)

Peripheral biomarkers of cognitive response to dopamine receptor agonist treatment
por: Ersche, Karen D., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_2va86esu3l6l6av3621j12rvcf